Dr. Martens CFO transfers shares to ISA accounts
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dr. Martens PLC (DOCS)
Dr. Martens PLC stock price live, this page displays LON DOCS stock exchange data. View the DOCS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dr. Martens PLC real time stock price chart below.
What Is the Dr. Martens PLC Stock Price Today?
The Dr. Martens PLC stock price today is 92.05.
What Is the Stock Symbol for Dr. Martens PLC?
The stock symbol for Dr. Martens PLC is ""DOCS.""
What Stock Exchange Does Dr. Martens PLC Trade On?
Dr. Martens PLC is listed and trades on the London stock exchange.
Is Dr. Martens PLC a Good Stock to Buy?
Determining whether Dr. Martens PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DOCS quote. (ISIN: GB00BL6NGV24)
What Is the Dr. Martens PLC Stock Price Today?
The Dr. Martens PLC stock price today is 92.05.
What Is the Stock Symbol for Dr. Martens PLC?
The stock symbol for Dr. Martens PLC is ""DOCS.""
What Stock Exchange Does Dr. Martens PLC Trade On?
Dr. Martens PLC is listed and trades on the London stock exchange.
Is Dr. Martens PLC a Good Stock to Buy?
Determining whether Dr. Martens PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DOCS quote. (ISIN: GB00BL6NGV24)
92.05
+1.60(+1.77%)
Closed·
Fair Value
An estimate of a Dr. Martens's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
86.85
92.60
52 wk Range
43.94
94.35
DOCS Scorecard
Full Analysis
Net income is expected to grow this year
DOCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Dr. Martens's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
86.8592.60
52 wk Range
43.9494.35
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.77%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.77%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DOCS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Dr. Martens's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
100.00
Upside
+8.64%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Dr. Martens CFO transfers shares to ISA accounts
- Investing.com
- Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Dr. Martens PLC Company Profile
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Compare DOCS to Peers and Sector
Metrics to compare | DOCS | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship RelationshipDOCSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 197.7x | 16.6x | 11.2x | |
PEG Ratio | −2.12 | −0.13 | 0.02 | |
Price/Book | 2.4x | 1.9x | 1.4x | |
Price / LTM Sales | 1.1x | 1.1x | 1.0x | |
Upside (Analyst Target) | 3.2% | 27.2% | 17.1% | |
Fair Value Upside | Unlock | 5.4% | 7.5% | Unlock |
Analyst Ratings
2 Buy
4 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 100.00
(+8.64% Upside)
Earnings
Latest Release
Jun 17, 2025
EPS / Forecast
0.03 / 0.0363
Revenue / Forecast
463.00M / 487.99M
People Also Watch
FAQ
What Stock Exchange Does Dr. Martens Trade On?
Dr. Martens is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Dr. Martens?
The stock symbol for Dr. Martens is "DOCS."
What Is the Dr. Martens Market Cap?
As of today, Dr. Martens market cap is 889.57M.
What Is Dr. Martens's Earnings Per Share (TTM)?
The Dr. Martens EPS (TTM) is 0.00.
When Is the Next Dr. Martens Earnings Date?
Dr. Martens will release its next earnings report on 26 Nov 2025.
From a Technical Analysis Perspective, Is DOCS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Dr. Martens Stock Split?
Dr. Martens has split 0 times.
How Many Employees Does Dr. Martens Have?
Dr. Martens has 2348 employees.
What is the current trading status of Dr. Martens (DOCS)?
As of 08 Sept 2025, Dr. Martens (DOCS) is trading at a price of 92.05, with a previous close of 92.05. The stock has fluctuated within a day range of 86.85 to 92.60, while its 52-week range spans from 43.94 to 94.35.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.